$3,977.95 travel Payment -- Teva Pharmaceuticals to Dr. Matthew Walker
Neurologist Matthew Walker Receives Travel and Lodging Payment from Teva Pharmaceuticals
This page provides a detailed analysis of a $3,977.95 travel payment from Teva Pharmaceuticals to Dr. Matthew Walker. Data is from the CMS Open Payments (Sunshine Act) database.
Payment Details
| Field | Value |
|---|---|
| Amount | $3,977.95 |
| Payment Type | travel |
| Payment Nature | Travel and Lodging |
| Pharmaceutical Company | Teva Pharmaceuticals |
| Physician | Dr. Matthew Walker |
| NPI Number | 1885421226 |
| Physician Specialty | Neurology |
| Location | New York, NY |
| Date of Payment | 2026-02-15 |
| Conflict Assessment | Low -- Routine |
AI-Powered Analysis of This Payment
The following analysis was generated by artificial intelligence to help patients understand the context, significance, and implications of this pharmaceutical payment. This analysis is not medical or legal advice.
Teva Pharmaceuticals made a $4.0K travel payment to Matthew Walker, a Neurology specialist in New York, NY. Matthew Walker received $3,977.95 from Teva Pharmaceuticals for travel and lodging on February 15, 2026. The payment was made to cover travel and lodging expenses. The payment was made by Teva Pharmaceuticals, a pharmaceutical company.
Patient Guidance: What This Payment Means for You
This payment was for travel and lodging expenses incurred by the physician. Always discuss your treatment options with your healthcare provider and ask about alternatives.
Payment Context: Is This Amount Normal?
Travel and lodging payments to neurologists can vary widely depending on conference attendance, research collaborations, and other professional activities.
Regulatory Context: Sunshine Act Requirements
This payment falls under the Sunshine Act's reporting requirements for payments made by manufacturers of drugs, devices, or medical supplies to physicians and teaching hospitals.
Related Topics
This payment is related to the following healthcare transparency topics:
- pharmaceutical-payments
- physician-payments
- travel-expenses
- neurology
- teva-pharmaceuticals
- open-payments
Understanding travel Payments
Travel and lodging payments cover transportation and accommodation expenses for physicians attending conferences, advisory board meetings, or speaking engagements sponsored by pharmaceutical companies. These payments can be substantial, particularly for international travel or multi-day events.
Frequently Asked Questions About This Payment
What was this $4.0K payment for?
This was a travel payment of $4.0K from Teva Pharmaceuticals to Matthew Walker, categorized as "Travel and Lodging". The payment was reported under the Sunshine Act (CMS Open Payments).
Does Matthew Walker accept pharmaceutical money?
Yes, Matthew Walker received this $4.0K payment from Teva Pharmaceuticals. Under the Sunshine Act, pharmaceutical companies must report all payments to physicians exceeding $10. You can view Matthew Walker's full payment history on the CMS Open Payments database or on this site.
Is it legal for doctors to accept pharma payments?
Yes, it is legal for physicians to receive payments from pharmaceutical companies. The Physician Payments Sunshine Act (2010) requires transparency by mandating that companies report all payments exceeding $10 to CMS. These payments include consulting fees, meals, travel, speaking fees, and research grants. The law does not prohibit payments but ensures public disclosure.
Should I be concerned about this travel payment?
A travel payment of $4.0K should be evaluated in context. Payment does not imply wrongdoing, but patients have the right to ask their doctor about pharmaceutical relationships.
How do I talk to my doctor about pharma relationships?
You can ask your doctor directly: "Do you receive payments from pharmaceutical companies?" and "Does this affect which medications you prescribe?" Most doctors will answer honestly. You can also verify payment data yourself through CMS Open Payments (openpaymentsdata.cms.gov). Consider asking about generic alternatives and whether the prescribed medication is the best option regardless of manufacturer relationships.
What types of pharma payments are most concerning?
Ownership interests and large consulting/speaking fees are generally considered more significant than meals or small educational grants. Research payments typically fund clinical studies and are common in academic medicine. The total volume and concentration of payments from a single company may be more telling than any individual payment. Patterns matter more than individual transactions.
Does pharma money affect what my doctor prescribes?
Research shows that even small payments can influence prescribing behavior. Studies published in JAMA Internal Medicine found that physicians who received meals costing as little as $20 were more likely to prescribe the promoted brand-name drug. However, many physician-industry interactions are legitimate professional activities. The key is transparency and awareness.
How does this compare to other doctors in Neurology?
To compare this payment against Neurology averages, check the full specialty breakdown on CMS Open Payments. Payment amounts vary widely by specialty and type. Neurology physicians may receive payments for consulting, speaking, or research that are standard for the field. Individual payments should be evaluated in the context of the doctor's full payment history.
What does this payment reveal about Matthew Walker's relationship with Teva Pharmaceuticals?
The payment amount is $3,977.95. This $4.0K travel payment is part of the transparency data reported under the Sunshine Act.
Is this payment amount typical for Neurology?
The payment type is 'travel'.
What should patients do after learning about this payment?
This payment was for travel and lodging expenses incurred by the physician.
What else should I know about this travel payment?
The payment nature is 'Travel and Lodging'.
Related Reports
Data from CMS Open Payments. Payment does not imply wrongdoing. Consult your healthcare provider about any concerns.